1. Home
  2. PLAG vs BOLT Comparison

PLAG vs BOLT Comparison

Compare PLAG & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Planet Green Holdings Corp.

PLAG

Planet Green Holdings Corp.

HOLD

Current Price

$0.59

Market Cap

8.4M

ML Signal

HOLD

Logo Bolt Biotherapeutics Inc.

BOLT

Bolt Biotherapeutics Inc.

HOLD

Current Price

$3.99

Market Cap

7.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLAG
BOLT
Founded
1986
2015
Country
United States
United States
Employees
45
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
7.3M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
PLAG
BOLT
Price
$0.59
$3.99
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$34.00
AVG Volume (30 Days)
787.4K
11.2K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
32.56
N/A
EPS
N/A
N/A
Revenue
$3,040,616.00
$7,695,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$133.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.07
52 Week Low
$0.49
$3.75
52 Week High
$4.49
$7.20

Technical Indicators

Market Signals
Indicator
PLAG
BOLT
Relative Strength Index (RSI) 30.53 47.66
Support Level $0.49 $3.87
Resistance Level $2.10 $4.46
Average True Range (ATR) 0.23 0.24
MACD -0.04 0.01
Stochastic Oscillator 7.64 32.17

Price Performance

Historical Comparison
PLAG
BOLT

About PLAG Planet Green Holdings Corp.

Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company is focused on the clinical development of BDC-4182, its claudin 18.2 ISAC. Its other pipeline programs include CEA ISAC program a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5, or CEA; PD-L1 ISAC utilizes a novel human anti-PD-L1 antibody conjugated to a next-generation TLR7/8 agonist payload via a non-cleavable linker; and BDC-3042, its dectin-2 agonist antibody program, developed to repolarize critical cells in the tumor microenvironment known as tumor associated macrophages. It operates in single segment.

Share on Social Networks: